BARKA Therapeutics ApS
CVR 44860627 · Private limited company (ApS) · Active · Medium risk
BARKA Therapeutics ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -605k and a net result of DKK -881k. CEO: Hamed Mozaffari Brodersen.
Bankruptcy risk for BARKA Therapeutics ApS
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44860627
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- c/o Afyx Therapeutics ApS, Slotsmarken 11
2970 Hørsholm - Municipality
- Hørsholm
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 60k
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -72.2% |
| Current ratio | 1,768% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 22 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Revenue | DKK 0 | DKK 0 |
| Gross profit | DKK -962k | DKK -51k |
| Net profit | DKK -881k | DKK -114k |
| Equity | DKK -605k | DKK 276k |
| Total assets | DKK 838k | DKK 1.6m |
| Cash | DKK 480k | DKK 1.6m |
| Short-term debt | DKK 47k | DKK 53k |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Grant Thornton, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 175 | ||
| 29 May 2024 – 31 Dec 2024 | 176 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Hamed Mozaffari Brodersen | Current | |
| Board | Ole Baadsgaard | Current | |
| Board | Karin Absalonsen | Current | |
| Board | Claus Juan Møller-San Pedro | Current | |
| Board | Hamed Mozaffari Brodersen | Current | |
| Owner (33%) | Afyx Capital ApS | Current | |
| Owner (67%) | Hannibal Innovation ApS | Current | |
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | Current | |
| Founder | Afyx Capital ApS | Current | |
| Founder | Hannibal Innovation ApS | Current |
The CEOs' other companies
Hamed Mozaffari Brodersen – 2 other companies
- Dania Therapeutics ApS Active
- Hannibal Innovation ApS Active
Address history (1 moves)
| c/o Afyx Therapeutics ApS, Slotsmarken 11, 2970 Hørsholm | |
| c/o Afyx Therapeutics ApS, Agern Alle 24, 2970 Hørsholm |
Other companies at the same address
- DM SOFTWARE A/S Bankrupt
- LISBERG ApS Bankrupt
- OM SOFTWARE ApS Bankrupt
- APPEER RESSOURCING A/S Opløst
- Afyx Development A/S Active
- Afyx Therapeutics A/S Active
- BUSINESS INFORMATION TECHNOLOGY A/S Compulsorily dissolved
- HØGSBERG ASSURANCE SERVICE A/S Fusioneret
- INFORMATION MANAGEMENT GROUP ApS Compulsorily dissolved
- INFORMATION MANAGEMENT GROUP HOLDING A/S Compulsorily dissolved
- INFORMATION QUALITY GROUP ApS Compulsorily dissolved
- KONTRON TECHNOLOGY ApS Opløst
- M&E ENGINEERING A/S Active
- NORBY Invest Holding ApS Active
- NORBY Management ApS Active
- PEER ERICSON HOLDING 2013 ApS Active
- PKHH HOLDING ApS Opløst
- S.U.1. ApS Compulsorily dissolved
- TAPLOW EXECUTIVE SEARCH ApS Active
- Taplow Executive Interim ApS Active
- Taplow Invest Holding ApS Active
- VSML HOLDING ApS Opløst
Similar companies in Hørsholm
- Keldmann Healthcare ApS Hørsholm
- Alfredsen Technology ApS Hørsholm
- Edge Biotechnologies ApS Hørsholm
- VAST Renewables ApS Hørsholm
- DesignWater ApS Hørsholm
- Sanos Supply A/S Hørsholm
- Invenio Lab ApS Hørsholm
- MICROLOCK ApS Hørsholm
- IFAU ApS Hørsholm
- PULMOVET A/S Hørsholm
- Renovaro Biosciences Denmark ApS Hørsholm
- Plantcarb ApS Hørsholm
Questions and answers about BARKA Therapeutics ApS
Has BARKA Therapeutics ApS gone bankrupt?
No, BARKA Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BARKA Therapeutics ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of BARKA Therapeutics ApS?
Hamed Mozaffari Brodersen is the CEO of BARKA Therapeutics ApS.
Who is the auditor of BARKA Therapeutics ApS?
BARKA Therapeutics ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.
When was BARKA Therapeutics ApS founded?
BARKA Therapeutics ApS was founded on 29 May 2024.
What is the equity of BARKA Therapeutics ApS?
Equity was DKK -605k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.